UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Ischemia depletes dystrophin and inhibits protein synthesis in the canine heart: mechanisms of myocardial ischemic injury

Journal of molecular and cellular cardiology, 2005-05, Vol.38 (5), p.723-733

2005

Volltextzugriff (PDF)

Effects of selective cyclooxygenase-2 inhibition on vascular responses and thrombosis in canine coronary arteries

Circulation (New York, N.Y.), 2001-08, Vol.104 (7), p.820-825

2001

Volltextzugriff (PDF)

Modulation of leukocyte-mediated myocardial reperfusion injury

Annual review of physiology, 1990-01, Vol.52 (1), p.561-576

LUCCHESI, B. R

1990

Volltextzugriff (PDF)

Prevention of arterial thrombosis by intravenously administered platelet P2T receptor antagonist AR-C69931MX in a canine model

The Journal of pharmacology and experimental therapeutics, 2000-11, Vol.295 (2), p.492

2000

Volltextzugriff (PDF)

The role of the neutrophil and free radicals in ischemic myocardial injury

Journal of molecular and cellular cardiology, 1989-12, Vol.21 (12), p.1241-1251

1989

Volltextzugriff (PDF)

Myocardial protection with preconditioning

Circulation (New York, N.Y.), 1990-08, Vol.82 (2), p.609-619

1990

Volltextzugriff (PDF)

Canine Myocardial Reperfusion Injury: Its Reduction by the Combined Administration of Superoxide Dismutase and Catalase

Circulation research, 1984-03, Vol.54 (3), p.277-285

1984

Volltextzugriff (PDF)

Reduction of experimental canine myocardial reperfusion injury by a monoclonal antibody (anti-Mo1, anti-CD11b) that inhibits leukocyte adhesion

The Journal of clinical investigation, 1988-02, Vol.81 (2), p.624-629

1988

Volltextzugriff (PDF)

Pharmacokinetics of cefpodoxime in plasma and subcutaneous fluid following oral administration of cefpodoxime proxetil in male beagle dogs

Journal of veterinary pharmacology and therapeutics, 2011-04, Vol.34 (2), p.130-135

2011

Volltextzugriff (PDF)

Thrombostatin inhibits cyclic flow variations in stenosed canine coronary arteries

Thrombosis and haemostasis, 2001-11, Vol.86 (5), p.1296-1304

2001

Volltextzugriff (PDF)

Reduction of the extent of ischemic myocardial injury by neutrophil depletion in the dog

Circulation (New York, N.Y.), 1983-05, Vol.67 (5), p.1016-1023

1983

Volltextzugriff (PDF)

Superoxide Dismutase Conjugated to Polyethylene Glycol Provides Sustained Protection Against Myocardial Ischemia/ Reperfusion Injury in Canine Heart

Circulation research, 1988-11, Vol.63 (5), p.944-959

1988

Volltextzugriff (PDF)

Thrombostatin inhibits induced canine coronary thrombosis

Thrombosis and haemostasis, 1999-09, Vol.82 (3), p.1182-1187

1999

Volltextzugriff (PDF)

Profibrillatory Actions of Pinacidil in a Conscious Canine Model of Sudden Coronary Death

Journal of cardiovascular pharmacology, 1990-03, Vol.15 (3), p.452-464

1990

Volltextzugriff (PDF)

Iloprost Inhibits Neutrophil Function In Vitro and In Vivo and Limits Experimental Infarct Size in Canine Heart

Circulation research, 1987-05, Vol.60 (5), p.666-673

1987

Volltextzugriff (PDF)

Antiplatelet antibody [7E3 F(ab')2] prevents rethrombosis after recombinant tissue-type plasminogen activator-induced coronary artery thrombolysis in a canine model

Circulation (New York, N.Y.), 1990-02, Vol.81 (2), p.617-627

1990

Volltextzugriff (PDF)

Identification of a Time Window for Therapy to Reduce Experimental Canine Myocardial Injury: Suppression of Neutrophil Activation During 72 Hours of Reperfusion

Circulation research, 1988-12, Vol.63 (6), p.1070-1079

1988

Volltextzugriff (PDF)

Sustained limitation of myocardial reperfusion injury by a monoclonal antibody that alters leukocyte function

Circulation (New York, N.Y.), 1990, Vol.81 (1), p.226-237

1990

Volltextzugriff (PDF)

Thrombolytic effects of recombinant fibrolase or APSAC in a canine model of carotid artery thrombosis

Circulation (New York, N.Y.), 1994-11, Vol.90 (5), p.2448-2456

1994

Volltextzugriff (PDF)

In vivo efficacy of SM-20302, a GP IIb/IIIa receptor antagonist, correlates with ex vivo platelet inhibition in heparinized blood but not in citrated blood

Arteriosclerosis, thrombosis, and vascular biology, 1998-06, Vol.18 (6), p.954-960

1998

Volltextzugriff (PDF)

Oral antiplatelet, antithrombotic efficacy of DMP 728, a novel platelet GPIIb/IIIa antagonist

Circulation (New York, N.Y.), 1996-02, Vol.93 (3), p.537-543

1996

Volltextzugriff (PDF)

Cardioprotective effects of heparin of N-acetylheparin in an in vivo model of myocardial ischaemic and reperfusion injury

Cardiovascular research, 1995-05, Vol.29 (5), p.629-636

1995

Volltextzugriff (PDF)

Reduction of the size of infarction by allopurinol in the ischemic-reperfused canine heart

Circulation (New York, N.Y.), 1986-03, Vol.73 (3), p.518-524

1986

Volltextzugriff (PDF)

The Independent Effects of Oxygen Radical Scavengers on Canine Infarct Size: Reduction by Superoxide Dismutase but not Catalase

Circulation research, 1985-06, Vol.56 (6), p.895-898

1985

Volltextzugriff (PDF)

Tedisamil in a Chronic Canine Model of Atrial Flutter

Journal of cardiovascular pharmacology, 1999-08, Vol.34 (2), p.212-218

1999

Volltextzugriff (PDF)

1 – 25 von 238

Suche als RSS-Feed

Aktive Filter

ThemaDogs

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(227)
Mit Volltextzugriff
(168)

Publikationsform

Artikel
(238)

Sprache

Englisch
(237)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Animals
(236)
Science & Technology
(198)
Life Sciences & Biomedicine
(196)
Male
(175)
Biological And Medical Sciences
(123)
Cardiovascular System & Cardiology
(123)
Medical Sciences
(121)
Cardiac & Cardiovascular Systems
(112)
Pharmacology & Pharmacy
(105)
Pharmacology. Drug Treatments
(103)
Cardiovascular System
(70)
Electrocardiography
(53)
Heart Rate - Drug Effects
(52)
Electric Stimulation
(44)
Myocardial Infarction - Physiopathology
(44)
Myocardial Infarction - Pathology
(43)
Blood Pressure - Drug Effects
(42)
Disease Models, Animal
(42)
Peripheral Vascular Disease
(42)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Ischemia depletes dystrophin and inhibits protein synthesis in the canine heart: mechanisms of myocardial ischemic injury

Effects of selective cyclooxygenase-2 inhibition on vascular responses and thrombosis in canine coronary arteries

Modulation of leukocyte-mediated myocardial reperfusion injury

Prevention of arterial thrombosis by intravenously administered platelet P2T receptor antagonist AR-C69931MX in a canine model

The role of the neutrophil and free radicals in ischemic myocardial injury

Myocardial protection with preconditioning

Canine Myocardial Reperfusion Injury: Its Reduction by the Combined Administration of Superoxide Dismutase and Catalase

Reduction of experimental canine myocardial reperfusion injury by a monoclonal antibody (anti-Mo1, anti-CD11b) that inhibits leukocyte adhesion

Pharmacokinetics of cefpodoxime in plasma and subcutaneous fluid following oral administration of cefpodoxime proxetil in male beagle dogs

Thrombostatin inhibits cyclic flow variations in stenosed canine coronary arteries

Reduction of the extent of ischemic myocardial injury by neutrophil depletion in the dog

Superoxide Dismutase Conjugated to Polyethylene Glycol Provides Sustained Protection Against Myocardial Ischemia/ Reperfusion Injury in Canine Heart

Thrombostatin inhibits induced canine coronary thrombosis

Profibrillatory Actions of Pinacidil in a Conscious Canine Model of Sudden Coronary Death

Iloprost Inhibits Neutrophil Function In Vitro and In Vivo and Limits Experimental Infarct Size in Canine Heart

Antiplatelet antibody [7E3 F(ab')2] prevents rethrombosis after recombinant tissue-type plasminogen activator-induced coronary artery thrombolysis in a canine model

Identification of a Time Window for Therapy to Reduce Experimental Canine Myocardial Injury: Suppression of Neutrophil Activation During 72 Hours of Reperfusion

Sustained limitation of myocardial reperfusion injury by a monoclonal antibody that alters leukocyte function

Thrombolytic effects of recombinant fibrolase or APSAC in a canine model of carotid artery thrombosis

In vivo efficacy of SM-20302, a GP IIb/IIIa receptor antagonist, correlates with ex vivo platelet inhibition in heparinized blood but not in citrated blood

Oral antiplatelet, antithrombotic efficacy of DMP 728, a novel platelet GPIIb/IIIa antagonist

Cardioprotective effects of heparin of N-acetylheparin in an in vivo model of myocardial ischaemic and reperfusion injury

Reduction of the size of infarction by allopurinol in the ischemic-reperfused canine heart

The Independent Effects of Oxygen Radical Scavengers on Canine Infarct Size: Reduction by Superoxide Dismutase but not Catalase

Tedisamil in a Chronic Canine Model of Atrial Flutter

Aktive Filter

Suchergebnisse filtern